GCOW - ETF AI Analysis
Top Page
Pacer Global Cash Cows Dividend ETF (GCOW)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, showing solid recent results for investors.
Resilient Top Holdings
Many of the largest positions, including tobacco, health care, and energy companies, have shown strong performance, helping support the fund’s overall returns.
Broad Global Diversification
The fund is spread across many countries, with meaningful exposure to the U.S., Europe, and Asia, which helps reduce the impact of problems in any single market.
Negative Factors
Relatively High Expense Ratio
The ETF’s fee is on the higher side compared with many broad market index funds, which can slightly reduce long-term returns.
Mixed Performance in Top Holdings
A few major positions, such as Unilever and Medtronic, have shown weaker performance, which can drag on the fund’s overall results.
Sector Concentration in Defensive Industries
Large weightings in consumer defensive and health care stocks mean the fund is less exposed to faster-growing areas like technology, which could limit upside in strong growth markets.
GCOW vs. SPDR S&P 500 ETF (SPY)
AUM3.45B
RegionDeveloped Markets
Expense Ratio0.60%
Beta0.36
IssuerPacer
Inception DateFeb 23, 2016
Dividend Yield4.58%
Asset ClassEquity
Index TrackedPacer Global Cash Cows Dividend Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume277,575
30 Day Avg. Volume276,065
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
51.11Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering100
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GCOW Summary
GCOW, the Pacer Global Cash Cows Dividend ETF, follows the Pacer Global Cash Cows Dividend Index and invests in large, established companies around the world that generate strong cash flows and pay steady dividends. It holds well-known names like Nestlé and Chevron, along with many other consumer, healthcare, and energy companies across the U.S., Europe, and Asia. Someone might invest in GCOW to get global diversification plus regular dividend income from financially solid businesses. A key risk is that the ETF’s stock prices and dividend payments can still go up and down with the overall market.
How much will it cost me?The Pacer Global Cash Cows Dividend ETF (GCOW) has an expense ratio of 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on selecting companies with strong free cash flow yields to provide consistent dividends. The higher cost reflects the strategic approach and specialized research involved in managing the fund.
What would affect this ETF?The Pacer Global Cash Cows Dividend ETF (GCOW) could benefit from stable demand in defensive sectors like Health Care and Consumer Defensive, which make up a significant portion of its holdings, especially during economic uncertainty. However, its exposure to Energy and Materials sectors may face challenges if commodity prices decline or if stricter environmental regulations impact profitability. Additionally, global economic conditions and interest rate changes could influence the performance of its large-cap multinational holdings.
GCOW Top 10 Holdings
GCOW leans heavily on global consumer staples and health care names, with tobacco giants Philip Morris and British American Tobacco helping to power returns as their shares keep rising on steady cash flows. Drugmakers Bristol-Myers Squibb and Novartis add a healthy dose of momentum, reinforcing the fund’s defensive tilt. Energy players Chevron and Canadian Natural are also pulling their weight, giving the ETF a solid backbone tied to commodity strength. On the softer side, Unilever and AT&T are more mixed, occasionally losing steam and modestly tugging on performance. Overall, it’s a diversified, developed-markets mix with no single stock dominating the story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Unilever | 2.24% | $77.11M | £102.18B | -6.95% | 72 Outperform | |
| Bristol-Myers Squibb | 2.17% | $74.84M | $133.41B | 47.66% | 78 Outperform | |
| Philip Morris | 2.06% | $71.16M | $297.41B | 17.10% | 61 Neutral | |
| Novartis AG | 2.03% | $70.07M | CHF231.75B | 34.41% | 80 Outperform | |
| Nestlé SA | 2.02% | $69.80M | CHF208.38B | 13.38% | 71 Outperform | |
| Medtronic | 2.01% | $69.35M | $109.30B | -4.42% | 80 Outperform | |
| British American Tobacco | 2.00% | $69.03M | £98.57B | 10.63% | 71 Outperform | |
| Canadian Natural | 1.98% | $68.20M | C$138.93B | 53.96% | 81 Outperform | |
| Chevron | 1.97% | $67.84M | $392.01B | 30.01% | 71 Outperform | |
| AT&T | 1.96% | $67.42M | $159.32B | -16.22% | 71 Outperform |
GCOW Technical Analysis
Positive
―
Price Trends
44.89
Positive
45.18
Positive
43.28
Positive
Market Momentum
0.55
Negative
65.45
Neutral
77.73
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GCOW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 45.13, equal to the 50-day MA of 44.89, and equal to the 200-day MA of 43.28, indicating a bullish trend. The MACD of 0.55 indicates Negative momentum. The RSI at 65.45 is Neutral, neither overbought nor oversold. The STOCH value of 77.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GCOW.
GCOW Peer Comparison
Comparison Results
Performance Comparison
GCOW
Pacer Global Cash Cows Dividend ETF
46.35
9.79
26.78%
URTH
iShares MSCI World ETF
―
―
―
GSWO
Goldman Sachs ActiveBeta World Equity ETF
―
―
―
WSML
iShares MSCI World Small-Cap ETF
―
―
―
IQSI
IQ Candriam ESG International Equity ETF
―
―
―
GDIV
Harbor Dividend Growth Leaders ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents